This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ikeda, U. Articles by Shimada, K. Search for Related Content PubMed PubMed Citation Articles by Ikeda, U. Articles by Shimada, K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB NITRIC OXIDE Related Collections Endothelium/vascular type/nitric oxide Risk Factors Smooth muscle proliferation and differentiation

(Circulation. 1999;99:1230-1235.)
© 1999 American Heart Association, Inc.

Basic Science Reports

Homocysteine Increases Nitric Oxide Synthesis in Cytokine-Stimulated Vascular Smooth Muscle Cells

Uichi Ikeda, MD, PhD; Michiyo Ikeda, MD, PhD; Seiji Minota, MD, PhD; Kazuyuki Shimada, MD, PhD

From the Departments of Cardiology (U.I., K.S.) and Clinical Immunology (M.I., S.M.), Jichi Medical School, Minamikawachi, Tochigi, Japan.

Correspondence to Uichi Ikeda, MD, PhD, Department of Cardiology, Jichi Medical School, Minamikawachi-Machi, Tochigi 329-04, Japan. E-mail uikeda{at}jichi.ac.jp

	Abstract

Top Abstract Introduction Methods Results Discussion References

 
Background—Elevated plasma homocysteine levels have been reported to be an independent risk factor for vascular disease. However, there have been no reports concerning the effects of homocysteine on the production of nitric oxide (NO), another modulator of vascular function and proliferation, by the vascular smooth muscle.

Methods and Results—We investigated the effects of homocysteine on NO synthesis by measuring the production of nitrite, a stable metabolite of NO, in cultured rat vascular smooth muscle cells (VSMCs). Incubation of cultures with interleukin (IL)-1ß 10 ng/mL for 24 hours caused a significant increase in nitrite generation. The IL-1ß–induced nitrite production by VSMCs was significantly increased by homocysteine in a dose-dependent manner. This effect of homocysteine was significantly inhibited in the presence of N^G-monomethyl-L-arginine or actinomycin D. The homocysteine-induced nitrite production was accompanied by increased inducible NO synthase mRNA and protein accumulation. Cysteine, glutathione, or hydrogen peroxide also increased nitrite accumulation in IL-1ß–stimulated VSMCs. Coincubation with the radical scavenger catalase or superoxide dismutase markedly reduced homocysteine-induced nitrite accumulation.

Conclusions—Homocysteine enhances NO synthesis in IL-1ß–stimulated VSMCs, and oxidative products are involved in the effect of homocysteine.

Key Words: homocysteine • interleukins • nitric oxide • muscle, smooth • free radicals

	Introduction

Top Abstract Introduction Methods Results Discussion References

 
The extensively characterized endothelium-derived relaxing factor NO is a short-lived free radical. NO is synthesized from L-arginine by 3 isoenzymes expressed either constitutively (neuronal, type I cNOS; endothelial, type III cNOS) or after stimulation by cytokines (inducible, type II iNOS).^{1 2} Inducible NO synthase (iNOS) has been identified in endotoxin- and cytokine-treated neutrophils, hepatocytes, endothelial cells, and myocardium.^{1 3} iNOS activity is also induced in aortic rings and cultured vascular smooth muscles by cytokines and endotoxins.^{4 5} It has also been demonstrated that iNOS was expressed after in vivo balloon injury of rat carotid arteries⁶ and in human atherosclerotic lesions.⁷ NOS induction in vascular smooth muscle cells (VSMCs) may play a role in local vascular injury associated with atherosclerosis by inhibiting smooth muscle cell proliferation as well as by limiting thrombus formation by preventing platelet adhesion and aggregation.

Homocysteinemia caused by homozygous cystathionine ß-synthase deficiency is associated with an increased incidence of vascular thrombosis and development of arteriosclerosis,^{8 9 10} and elevated plasma homocysteine levels have been reported to be an independent risk factor for vascular disease.^{11 12 13 14 15} Furthermore, the administration of homocysteine caused vascular injury and thrombosis in animals.¹⁶ The mechanisms by which homocysteinemia leads to thrombosis and arteriosclerosis have not been completely defined. Recent studies using cell culture systems have shown that homocysteine enhances endothelial cell–associated factor V activity¹⁷ and inhibits both thrombomodulin surface expression and protein C activation.^{18 19 20} We also reported that homocysteine inhibited expression of the anticoagulant heparan sulfate in endothelial cells.²¹ In addition to its effect on endothelial cells, Tsai et al²² recently reported that homocysteine increased DNA synthesis in VSMCs and induced their proliferation. However, the effects of homocysteine on the production of NO, another modulator of vascular function and proliferation, by the vascular smooth muscle have been less well studied.²³ Therefore, in this study, we investigated the effects of homocysteine on NO synthesis in cultured rat VSMCs.

	Methods

Top Abstract Introduction Methods Results Discussion References

 
Materials
Human recombinant interleukin (IL)-1ß (specific activity, 2x10⁷ U/mg) was a gift from Otsuka Pharmacy (Tokushima, Japan). A mouse macrophage iNOS cDNA probe was a gift from Dr Kawahara (Kobe University School of Medicine, Hyogo, Japan).⁴ A monoclonal anti-mouse iNOS antibody, which cross-reacts with rat iNOS, was obtained from Transduction Laboratory. Homocysteine, cysteine, glutathione, and hydrogen peroxide were purchased from Nacalai Tesque Inc. N^G-Monomethyl-L-arginine (L-NMMA) and actinomycin D were from Sigma Chemical Co. Superoxide dismutase and catalase were from Seikagaku Kogyo. All other chemicals used were of the highest grade commercially available.

Cell Culture
Primary cultures of VSMCs were obtained from the media of thoracic aortas of Sprague-Dawley rats (200 to 250 g), as described previously.²⁴ The cells were grown in DMEM supplemented with 10% FCS, 100 U/mL penicillin, and 100 µg/mL streptomycin. The cultures were harvested twice a week by treatment with 0.125% trypsin and passaged at a 1:3 ratio in 100-mm culture dishes. A typical experiment was performed with cultured cells at passage levels 5 to 10. Cells (3x10⁴/mL) were plated in 24-well or 100-mm culture dishes in DMEM, supplemented as described above, and allowed to grow to subconfluence for 24 to 48 hours, after which they were preincubated in DMEM containing 0.5% FCS and supplemented with insulin (5 µg/mL) and transferrin (5 µg/mL) for 24 hours and used for the experiments described below.

This investigation was performed in accordance with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH publication 85-23, revised 1985).

Measurements of Nitrite
NO production by the cultured cells was determined by measurement of the nitrite contents of the culture medium.²⁵ VSMCs plated in 24-well dishes were incubated in DMEM containing 0.5% FCS at 37°C. The nitrite contents of culture media were determined by mixing 500 µL of medium with an equal volume of Griess reagent (1 part 0.1% naphthylethylenediamine dihydrochloride to 1 part 1% sulfanilamide in 5% phosphoric acid).²⁶ The absorbance at 550 nm was measured, and the nitrite concentration was determined by interpolation of a calibration curve of standard sodium nitrite concentrations against absorbance. After a washing, cells were dissolved in 0.2 mL of 1% SDS and used for protein assay (Bio-Rad assay kit) with BSA as a standard. Nitrite levels were corrected by protein measurement, and data are shown as nmol/mg protein.

Assay of iNOS mRNA
Total RNA was extracted from VSMCs plated in 100-mm culture dishes by the acid guanidinium isothiocyanate–phenol-chloroform method, and 30-µg aliquots were subjected to electrophoresis on 1% agarose gels. After electrophoretic separation, RNA was transferred onto nylon filters, which were then hybridized with a random-primed [³²P]-labeled mouse macrophage iNOS cDNA probe for 24 hours,⁴ followed by 2 washings with an aqueous solution of 150 mmol/L NaCl, 15 mmol/L sodium citrate, and 0.1% SDS at 65°C. The filters were exposed to Kodak XAR-5 film for 1 to 2 days at -70°C with 1 intensifying screen.

Assay for iNOS Protein
The expression of iNOS protein was analyzed by immunoblotting with an anti-iNOS antibody as described previously.²⁷ Briefly, cells were lysed in a buffer containing 50 mmol/L Tris/HCl (pH 7.5), 1 mmol/L EDTA, 1 µmol/L leupeptin, 1 µmol/L pepstatin A, 0.1 mmol/L PMSF, and 1 mol/L dithiothreitol and sonicated. The homogenates were then centrifuged at 100 000g for 20 minutes, and the supernatants (60 µg protein) were subjected to 10% SDS-PAGE. The separated proteins were electrophoretically transferred onto nitrocellulose membranes, and the resultant blots were incubated with the anti–iNOS antibody for 2 hours followed by peroxidase-labeled donkey anti-rabbit IgG for 1 hour. Peroxidase-labeled proteins were detected with the ECL detection system (Amersham) on x-ray film; the results were quantified by densitometric scanning.

Statistical Analysis
Data are expressed as mean±SEM of 4 samples, which represented 3 separate experiments. Differences were analyzed by 1-way ANOVA combined with Scheffé's test, and a value of P<0.05 was considered to be statistically significant.

	Results

Top Abstract Introduction Methods Results Discussion References

 
Effects of Homocysteine on Nitrite Production
First, we investigated the effects of IL-1ß on nitrite production by VSMCs. As shown in Figure 1, addition of IL-1ß 10 ng/mL stimulated nitrite production by VSMCs in a time-dependent manner. This IL-1ß–stimulated nitrite accumulation was significantly increased by simultaneous treatment of the cells with homocysteine 1 mmol/L. After a 24-hour incubation, the level of IL-1ß–stimulated nitrite accumulation in the presence of homocysteine was 1.5- to 2-fold that in the absence of homocysteine.

View larger version (13K): [in this window] [in a new window]   Figure 1. Time course of nitrite accumulation stimulated by IL-1ß in presence or absence of homocysteine in VSMCs. Cells were unstimulated () or stimulated with 10 ng/mL IL-1ß in presence () or absence () of 1 mmol/L homocysteine for various periods as indicated. Nitrite accumulation in culture medium was measured as described in Methods, and values were normalized to protein content per well. Points and bars represent mean±SEM (n=4). *P<0.05 vs IL-1ß–stimulated cells.

The effect of IL-1ß on nitrite production by VSMCs was dose-dependent (Figure 2). Addition of homocysteine 1 mmol/L to the culture further enhanced IL-1ß–induced nitrite production.

View larger version (27K): [in this window] [in a new window]   Figure 2. Dose-dependent effects of IL-1ß on nitrite production by VSMCs. Cells were exposed to various concentrations of IL-1ß (0.1 to 100 ng/mL) for 24 hours with (solid columns) or without (hatched columns) homocysteine (1 mmol/L). Nitrite accumulation in culture medium was measured, and values were normalized to protein content per well. Data represent mean±SEM (n=4). *P<0.05.

Figure 3 shows the dose-response relationship of the effect of homocysteine on NO synthesis. Homocysteine increased IL-1ß–stimulated nitrite production by VSMCs in a dose-dependent manner. Homocysteine by itself did not affect the basal level of nitrite production.

View larger version (18K): [in this window] [in a new window]   Figure 3. Dose-dependent effects of homocysteine on nitrite accumulation. VSMCs were incubated for 24 hours with (solid columns) or without (hatched columns) 10 ng/mL IL-1ß in presence of various concentrations of homocysteine (10-6 to 10-3 mol/L) as indicated. Nitrite accumulation in culture medium was measured, and values were normalized to protein content per well. Data represent mean±SEM (n=4). *P<0.05 vs control cells without homocysteine.

As shown in Figure 4, in the presence of the NOS inhibitor L-NMMA 1 mmol/L or the RNA synthesis inhibitor actinomycin D 5 µg/mL, the effects of homocysteine and IL-1ß were completely abolished.

View larger version (12K): [in this window] [in a new window]   Figure 4. Effects of L-NMMA and actinomycin D on IL-1ß– and homocysteine-induced nitrite accumulation in VSMCs. Cells were incubated for 24 hours with 1 mmol/L homocysteine (HCY), 10 ng/mL IL-1ß, 1 mmol/L L-NMMA, and/or 5 µg/mL actinomycin D (AMD). Nitrite accumulation in culture medium was measured, and values were normalized to protein content per well. Data represent mean±SEM (n=4). *P<0.05 vs control cells (-).

Effects of Homocysteine on iNOS mRNA and Protein Levels
We then examined whether homocysteine induced an increase in iNOS mRNA accumulation in VSMCs. As shown in Figure 5, unstimulated cells did not express iNOS mRNA. Incubation with IL-1ß for 24 hours resulted in an induction of iNOS mRNA expression, and its expression was further increased in the presence of homocysteine at >0.1 mmol/L.

View larger version (102K): [in this window] [in a new window]   Figure 5. Expression of iNOS mRNA in VSMCs. Cells were incubated with 10 ng/mL IL-1ß for 24 hours in presence of various concentrations of homocysteine (10-6 to 10-3 mol/L) as indicated. iNOS mRNA and 28S and 18S ribosomal RNAs visualized by ethidium bromide staining under UV transillumination are shown. Two independent experiments yielded identical results.

The expression of iNOS protein by homocysteine was also analyzed by immunoblotting with the anti-iNOS antibody (Figure 6). No immunoreactive band of iNOS was detected in unstimulated VSMCs. The iNOS protein band with a molecular mass of 125 kDa appeared clearly after exposure to IL-1ß for 24 hours, and its accumulation was further increased in the presence of homocysteine.

View larger version (30K): [in this window] [in a new window]   Figure 6. Expression of iNOS protein in VSMCs. A, Western blot depicting iNOS protein accumulation. Cells were incubated with 10 ng/mL IL-1ß for 24 hours with or without 1 mmol/L homocysteine. Cell extracts were subjected to SDS-PAGE followed by immunoblotting analysis. iNOS protein was detected as having a molecular mass of 125 kDa. Lane 1, vehicle; lane 2, IL-1ß; lane 3, IL-1ß plus homocysteine; lane 4, positive control (mouse macrophage iNOS). B, Densitometry values (in arbitrary densitometry units) of iNOS protein in Western blot. Data represent mean±SEM (n=3). *P<0.05 vs IL-1ß–stimulated cells.

Involvement of Oxidants in the Action of Homocysteine
We investigated the mechanism of the stimulatory effect of homocysteine on nitrite production. Oxygen-derived molecules such as superoxide and hydrogen peroxide generated by way of the reactive sulfhydryl (SH) group are thought to account for the endothelial cytotoxicity of homocysteine.^{28 29} We thus investigated the involvement of these molecules in homocysteine-induced nitrite production. First we investigated the effect of other molecules containing the SH group, cysteine, and glutathione. As shown in Figure 7, both cysteine and glutathione also enhanced nitrite production by IL-1ß–stimulated VSMCs. Furthermore, the effect of homocysteine was not maintained in the presence of glutathione (Figure 8).

View larger version (17K): [in this window] [in a new window]   Figure 7. Effects of cysteine and glutathione on nitrite accumulation. VSMCs were incubated for 24 hours with (solid columns) or without (hatched columns) 10 ng/mL IL-1ß in presence of 1 mmol/L cysteine (CYS) or 1 mmol/L glutathione (GSH). Nitrite accumulation in culture medium was measured, and values were normalized to protein content per well. Data represent mean±SEM (n=4). *P<0.05.

View larger version (14K): [in this window] [in a new window]   Figure 8. Effects of homocysteine on nitrite accumulation in presence of glutathione. Cells were incubated with 10 ng/mL IL-1ß for 24 hours in presence of 1 mmol/L homocysteine (HCY) and/or 5 mmol/L glutathione (GSH). Nitrite accumulation in culture medium was measured, and values were normalized to protein content per well. Data represent mean±SEM (n=4). *P<0.05.

We next examined the effect of hydrogen peroxide on nitrite production. Addition of hydrogen peroxide dose-dependently (0.01 to 0.1 mmol/L) increased nitrite production by IL-1ß–stimulated cells, whereas it did not affect the basal level of nitrite production (Figure 9).

View larger version (19K): [in this window] [in a new window]   Figure 9. Effects of hydrogen peroxide on nitrite accumulation. VSMCs were incubated for 24 hours with (solid columns) or without (hatched columns) 10 ng/mL IL-1ß in presence of hydrogen peroxide (0.01 to 0.1 mmol/L). Nitrite accumulation in culture medium was measured, and values were normalized to protein content per well. Data represent mean±SEM (n=4). *P<0.05 vs control cells without hydrogen peroxide.

We then investigated whether radical scavengers could inhibit the effect of homocysteine. As shown in Figure 10, addition of the radical scavenger catalase 1000 U/mL or superoxide dismutase 1000 U/mL markedly reduced homocysteine-induced nitrite accumulation.

View larger version (32K): [in this window] [in a new window]   Figure 10. Effects of radical scavengers on effect of homocysteine. Cells were incubated for 24 hours with 10 ng/mL IL-1ß, 1000 U/mL catalase (CAT), and/or 1000 U/mL superoxide dismutase (SOD) in presence (solid columns) or absence (hatched columns) of 1 mmol/L homocysteine. Nitrite accumulation in culture medium was measured, and values were normalized to protein content per well. (-) indicates control cells. Data represent mean±SEM (n=4). *P<0.05.

	Discussion

Top Abstract Introduction Methods Results Discussion References

 
Despite considerable epidemiological evidence identifying homocysteine as a risk factor for arteriosclerosis, the molecular mechanisms underlying homocysteine-induced arteriosclerosis have not been fully elucidated. Injury of vascular endothelial cells has been implicated in the pathogenesis of arteriosclerosis, and previous studies on homocysteine-induced atherosclerosis and thrombosis have focused on endothelial cells.^{18 30 31 32} However, Tsai et al^{22 33} showed that homocysteine increased DNA synthesis in cultured VSMCs, suggesting that homocysteine also acts directly on the vascular smooth muscle. In this study, we investigated whether homocysteine modulated NO synthesis in VSMCs. Although homocysteine by itself showed no effect on NO production, it augmented IL-1ß–induced NO production in a dose-dependent manner. The stimulatory effect of homocysteine was abolished when actinomycin D was present, suggesting that the augmentation of nitrite production by homocysteine is due to induction of iNOS. Indeed, we observed that homocysteine increased IL-1ß–induced iNOS mRNA and protein accumulation in VSMCs. The concentrations of homocysteine used did not exhibit any cytotoxic effects on VSMCs, judging from ⁵¹Cr release from the cells (data not shown).

Damage to the vascular endothelium by homocysteine is believed to be secondary to oxidative product formation accompanying oxidation of the SH group of the amino acid.^{28 29} We previously reported that the radical scavenger catalase blocked the effect of homocysteine on endothelial glycosaminoglycan metabolism.²¹ We thus investigated the involvement of oxygen-derived molecules in homocysteine-induced NO production by VSMCs and found that hydrogen peroxide as well as cysteine and glutathione also enhanced NO production, and the radical scavenger catalase and superoxide dismutase significantly inhibited the effect of homocysteine as well as those of cysteine and glutathione (data not shown). Furthermore, the effect of homocysteine was not maintained in the presence of glutathione. These results suggest that oxidative products are involved in the action of homocysteine, although the precise mechanism remains obscure. Welch et al²³ recently reported that homocysteine induced NO synthesis in VSMCs by NF-B–dependent transcriptional activation of iNOS.

In the present study, homocysteine significantly increased IL-1ß–stimulated NO production at 0.1 to 1 mmol/L. The effect of homocysteine occurred at the same concentrations as used in previous experiments.^{17 18 19 20 21 22} Atherosclerosis appears to be associated with homocysteine concentrations of 0.2 to 0.25 mmol/L in hyperhomocysteinemic patients, although levels of homocysteine found in the plasma of patients with vascular diseases are considerably lower than those in homozygous homocysteinemic patients.^{11 12 13 14} For example, the Physicians' Health Study demonstrated that patients with plasma homocysteine levels >15.8 µmol/L had a 3-fold increase in the risk of myocardial infarction.¹² Whether such low levels of homocysteine could affect NO synthesis in vivo is unknown.

iNOS activity is induced in blood vessel wall and cultured VSMCs by endotoxins and cytokines.⁵ Joly et al⁶ demonstrated that in vivo balloon injury induced NOS activity in rat carotid arteries, even in the absence of endothelium. Hansson et al³⁴ reported that arterial smooth muscle cells in the neointima formed after deendothelializing balloon injury of the rat carotid artery expressed the cytokine-inducible isoform of NOS. Buttery et al⁷ also reported that iNOS mRNA and protein were present within human arteriosclerotic lesions. NO production by VSMCs may in part compensate for the absence of endothelial NO synthesis by inhibiting smooth muscle cell proliferation, as well as by limiting thrombus formation by preventing platelet adhesion and aggregation.^{35 36 37} This hypothesis is supported by the observation in animals that L-arginine attenuates neointimal formation after balloon injury³⁸ or that iNOS suppresses the development of allograft arteriosclerosis.³⁹ Thus, homocysteine-induced NO may suppress the atherothrombotic risk of hyperhomocysteinemic states. However, the potential role of excess NO derived from iNOS in the vascular tissue under pathological conditions has not been fully characterized and is still controversial. NO also has toxic and cytolytic effects, and increased expression of iNOS may promote the process of atherogenesis by increasing cell death and necrosis.

In conclusion, homocysteine enhances NO synthesis in IL-1ß–stimulated VSMCs, and oxidative products are involved in the effect of homocysteine. However, further studies are necessary to clarify the role of homocysteine in NO production by the vascular tissue and its involvement in the pathogenesis of vascular lesions.

	Acknowledgments

 
This study was supported by the Ministry of Education, Science, Sports, and Culture Japan and Sankyo Foundation of Life Science.

Received June 19, 1998; revision received October 7, 1998; accepted October 26, 1998.

	References

Top Abstract Introduction Methods Results Discussion References

 

1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev. 1991;43:109–140.[Medline] [Order article via Infotrieve]
   
2. Nathan C, Xie Q. Regulation of biosynthesis of nitric oxide. J Biol Chem. 1994;269:13725–13728.[Free Full Text]
   
3. Shindo T, Ikeda U, Ohkawa F, Takahashi M, Funayama H, Nishinaga M, Kawahara Y, Yokoyama M, Shimada K. Nitric oxide synthesis in rat cardiac myocytes and fibroblasts. Life Sci. 1994;55:1101–1108.[Medline] [Order article via Infotrieve]
   
4. Koide M, Kawahara Y, Tsuda T, Yokoyama M. Cytokine-induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells. FEBS Lett. 1993;318:213–217.[Medline] [Order article via Infotrieve]
   
5. Dinerman JL, Lowenstein CJ, Snyder SH. Molecular mechanisms of nitric oxide regulation. Circ Res. 1993;73:217–222.[Free Full Text]
   
6. Joly GA, Schini VB, Vanhoutte PM. Balloon injury and interleukin-1ß induce nitric oxide synthase activity in rat carotid arteries. Circ Res. 1992;71:331–338.[Abstract/Free Full Text]
   
7. Buttery LD, Springall DR, Chester AH, Evans TJ, Standfield EN, Parums DV, Yacoub MH, Polak JM. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest. 1996;75:77–85.[Medline] [Order article via Infotrieve]
   
8. Mudd SH, Skovby FS, Levy HL, Pettigrew KD, Wilcken B, Pyeritz RE, Andria G, Boers GHJ, Bromberg IL, Cerone R, Fowler B, Grobe H, Schmidt H, Schweitzer C. The natural history of homocystinuria due to cystathione ß-synthase deficiency. Am J Hum Genet. 1985;37:1–31.[Medline] [Order article via Infotrieve]
   
9. Selhub J, D'Angelo A. Hyperhomocysteinemia and thrombosis: acquired conditions. Thromb Haemost. 1997;78:527–531.[Medline] [Order article via Infotrieve]
   
10. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PWF, Belanger AJ, O'Leary DH, Wolf PA, Schaefer EJ, Rosenberg IH. Association between plasma homocyst(e)ine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995;332:286–291.[Abstract/Free Full Text]
    
11. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324:1149–1155.[Abstract]
    
12. Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, Tishler PV, Henneckens CH. A prospective study of plasma homocysteine and risk of myocardial infarction in US physicians. J Am Med Assoc. 1992;268:877–881.[Abstract]
    
13. Mainlow MR. Hyperhomocysteinemia: a common and easily reversible risk factor for occlusive atherosclerosis. Circulation. 1990;81:2004–2006.[Free Full Text]
    
14. Harker LA, Slichter SJ, Scott CR, Ross R. Homocystinemia: vascular injury and arterial thrombosis. N Engl J Med. 1974;291:537–543.
    
15. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA. 1995;274:1049–1057.[Abstract]
    
16. Harker LA, Ross R, Slichter SJ, Scott CR. Homocysteine-induced arteriosclerosis: the role of endothelial cell injury and platelet response in its genesis. J Clin Invest. 1976;58:731–741.
    
17. Rodgers GM, Kane WH. Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activation. J Clin Invest. 1986;77:1909–1916.
    
18. Hayashi T, Honda G, Suzuki K. An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells. Blood. 1992;79:2930–2936.[Abstract/Free Full Text]
    
19. Rodgers GM, Conn MT. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells. Blood. 1990;75:895–901.[Abstract/Free Full Text]
    
20. Lentz SR, Sadler JE. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J Clin Invest. 1991;88:1906–1914.
    
21. Nishinaga M, Ozawa T, Shimada K. Homocysteine, a thrombogenic agent, suppresses anticoagulant heparan sulfate expression in cultured porcine aortic endothelial cells. J Clin Invest. 1993;92:1381–1386.
    
22. Tsai J, Perrella MA, Yoshizumi M, Hsieh C, Haber E, Schlegel R, Lee M. Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci U S A. 1994;91:6369–6373.[Abstract/Free Full Text]
    
23. Welch GN, Upchurch GR Jr, Farivar RS, Pigazzi A, Vu K, Brecher P, Keaney JF Jr, Loscalzo J. Homocysteine-induced nitric oxide production in vascular smooth-muscle cells by NF-B-dependent transcriptional activation of Nos 2. Proc Assoc Am Physicians. 1998;110:22–31.[Medline] [Order article via Infotrieve]
    
24. Ikeda U, Ikeda M, Oohara T, Oguchi A, Kamitani T, Tsuruya Y, Kano S. Interleukin 6 stimulates growth of vascular smooth muscle cells in a PDGF-dependent manner. Am J Physiol. 1991;260:H1713–H1717.[Abstract/Free Full Text]
    
25. Ikeda U, Kanbe T, Kawahara Y, Yokoyama M, Shimada K. Adrenomedullin augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes. Circulation. 1996;94:2560–2565.[Abstract/Free Full Text]
    
26. Green LC, Wagner DA, Glogowski J, Skiper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite and [¹⁵N]nitrate in biological fluids. Anal Biochem. 1982;126:131–138.[Medline] [Order article via Infotrieve]
    
27. Ikeda U, Kurosaki K, Shimpo M, Okada K, Saito T, Shimada K. Adenosine stimulates nitric oxide synthesis in rat cardiac myocytes. Am J Physiol. 1997;273:H59–H65.[Abstract/Free Full Text]
    
28. Wall RT, Horlan JM, Harker LA, Striker GE. Homocyst(e)ine-induced endothelial injury in vitro: a model for the study of vascular injury. Thromb Res. 1980;18:113–121.[Medline] [Order article via Infotrieve]
    
29. Starkebaum G, Harlan JM. Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocyst(e)ine. J Clin Invest. 1986;77:1370–1376.
    
30. Lentz SR, Sadler JE. Homocysteine inhibits von Willebrand factor processing and secretion by preventing transport from the endoplasmic reticulum. Blood. 1993;81:683–689.[Abstract/Free Full Text]
    
31. Hajjar KA. Homocysteine-induced modulation of tissue plasminogen activator binding to its endothelial cell membrane receptor. J Clin Invest. 1993;91:2873–2879.
    
32. Stamler JS, Osborne JA, Jaraki O, Rabbani LE, Mullins M, Singel D, Loscalzo J. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest. 1993;91:308–318.
    
33. Tsai J, Wang H, Perrella MA, Yoshizumi M, Sibinga NES, Tan LC, Haber E, Chang TH, Schlegel R, Lee M. Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells. J Clin Invest. 1996;97:146–153.[Medline] [Order article via Infotrieve]
    
34. Hansson GK, Geng Y, Holm J, Hårdhammar P, Wennmalm Å, Jennische E. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J Exp Med. 1994;180:733–738.[Abstract/Free Full Text]
    
35. Wennmalm Å. Endothelial nitric oxide and cardiovascular disease. J Intern Med. 1994;235:317–327.[Medline] [Order article via Infotrieve]
    
36. Lloyd-Jones D, Bloch KD. The vascular biology of nitric oxide and its role in atherogenesis. Annu Rev Med. 1996;47:365–375.[Medline] [Order article via Infotrieve]
    
37. Yan Z, Yokota T, Zhang W, Hansson GK. Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. Circ Res. 1996;79:38–44.[Abstract/Free Full Text]
    
38. Hamon M, Vallet B, Bauters C, Wernert N, McFadden EP, Lablanche JM, Dupuis B, Bertrand ME. Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury. Circulation. 1994;90:1357–1362.[Abstract/Free Full Text]
    
39. Shears II LL, Kawaharada N, Tzeng E, Billiar TR, Watkins SC, Kovesdi I, Lizonova A, Pham SM. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. J Clin Invest. 1997;100:2035–2042.[Medline] [Order article via Infotrieve]
    

This article has been cited by other articles:

				I. Qureshi, H. Chen, A. T Brown, R. Fitzgerald, X. Zhang, J. Breckenridge, R. Kazi, A. J Crocker, M. C Stuhlingexsr, K. Lin, et al. Homocysteine-induced vascular dysregulation is mediated by the NMDA receptor Vascular Medicine, August 1, 2005; 10(3): 215 - 223. [Abstract] [PDF]

				S. Kishi, J. Griener, C. Cheng, S. Das, E. H. Cook, D. Pei, M. Hudson, J. Rubnitz, J. T. Sandlund, C.-H. Pui, et al. Homocysteine, Pharmacogenetics, and Neurotoxicity in Children With Leukemia J. Clin. Oncol., August 15, 2003; 21(16): 3084 - 3091. [Abstract] [Full Text] [PDF]

				U. Ikeda, Y. Maeda, K. Yamamoto, and K. Shimada C-Reactive protein augments inducible nitric oxide synthase expression in cytokine-stimulated cardiac myocytes Cardiovasc Res, October 1, 2002; 56(1): 86 - 92. [Abstract] [Full Text] [PDF]

				G. Wang, Y. L. Siow, and K. O Homocysteine induces monocyte chemoattractant protein-1 expression by activating NF-{kappa}B in THP-1 macrophages Am J Physiol Heart Circ Physiol, June 1, 2001; 280(6): H2840 - H2847. [Abstract] [Full Text] [PDF]

				J. Crott and M. Fenech Preliminary study of the genotoxic potential of homocysteine in human lymphocytes in vitro Mutagenesis, May 1, 2001; 16(3): 213 - 217. [Abstract] [Full Text] [PDF]

				H. Chen, U. Ikeda, M. Shimpo, M. Ikeda, S. Minota, and K. Shimada Fluvastatin Upregulates Inducible Nitric Oxide Synthase Expression in Cytokine-Stimulated Vascular Smooth Muscle Cells Hypertension, December 1, 2000; 36(6): 923 - 928. [Abstract] [Full Text] [PDF]

				P. A. Detmers, M. Hernandez, J. Mudgett, H. Hassing, C. Burton, S. Mundt, S. Chun, D. Fletcher, D. J. Card, J. Lisnock, et al. Deficiency in Inducible Nitric Oxide Synthase Results in Reduced Atherosclerosis in Apolipoprotein E-Deficient Mice J. Immunol., September 15, 2000; 165(6): 3430 - 3435. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ikeda, U. Articles by Shimada, K. Search for Related Content PubMed PubMed Citation Articles by Ikeda, U. Articles by Shimada, K. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB NITRIC OXIDE Related Collections Endothelium/vascular type/nitric oxide Risk Factors Smooth muscle proliferation and differentiation